Aldeyra The share price logo

Aldeyra The Share Price

NASDAQ: ALDX

Small Cap

$1.69

-0.09

(-5.06%)

as on

Aldeyra The Stock Performance

as on April 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.68
    $1.83
    downward going graph

    0.59%

    Downside

    8.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.07
    $6.18
    downward going graph

    36.69%

    Downside

    265.38%

    Upside

    downward going graph

Aldeyra The share price movements today

Previous Close
$1.78
Open
$1.79
Volume
2.0M
Day's Low - High
$1.68 - $1.83
52 Week Low - High
$1.07 - $6.18

Aldeyra The Historical Returns

1 Month Return
-1.66 %
3 Month Return
-64.33 %
1 Year Return
-20.54 %
3 Year Return
-82.24 %
5 Year Return
-84.97 %

Aldeyra The Stock Fundamentals & Key Indicators

Check Aldeyra The market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$108.3M

EPS (TTM)

-0.4033

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-35.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-58.73%

Aldeyra The vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aldeyra The with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Aldeyra The image
Aldeyra The
BUY$108.3M-84.97%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B126.09%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.7B99.85%28.6532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.5BNA128.255.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B47.96%18.0531.41%

Stock Returns calculator for Aldeyra The Stock including INR - Dollar returns

The Aldeyra The stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aldeyra The investment value today

Current value as on today

₹82,820

Returns

-₹17,180

(-17.18%)

Returns from Aldeyra The Stock

-₹24,554 (-24.55%)

Dollar Impact

₹7,374 (+7.37%)

Analyst Recommendation on Aldeyra The Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Aldeyra The. Average target price of $7.5

Aldeyra The Share Price Target

Get share price movements and forecasts by analysts on Aldeyra The.

What analysts predicted

77.47%UPSIDE

Target Price

$7.5

Current Price

$1.69

Analyzed by

14 Analysts

Target

$7.50

Aldeyra The target price $7.5, a slight upside of 77.47% compared to current price of $1.69. According to 14 analysts rating.

Aldeyra The Stock’s Investor Sentiment and Interest

Investment in Aldeyra The Shares on INDmoney has dropped by -35.57% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-35.57% versus previous 30 day period

Search interest for Aldeyra The Stock has increased by 70% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:70% versus previous 30 day period

Aldeyra The Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-9
-6
-9
-18
-16
-16
-10
-10
-8
-6
EBITDA
-7
-4
-7
-16
-14
-15
-9
-9
-7
1,085,382
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-4
-8
-16
-15
-15
-9
-9
-7
-6
Income Tax Expense
1
-3
0
0
-
0
-
-
-
-
Net Income
-8
-4
-8
-16
-15
-15
-9
-9
-7
-6
Net Profit Margin
0.00%
-1210.58%
0.00%
0.00%
0.00%
-6465.07%
0.00%
0.00%
0.00%
0.00%

Aldeyra The Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-18
-22
-39
-63
-34
-56
-62
-42
-60
-35
EBITDA
-18
-22
-38
-61
-36
-55
-60
-35
-53
-31
Interest Expense
0
0
0
0
1
1
1
2
1
1
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-18
-22
-38
-62
-38
-57
-62
-37
-55
-33
Income Tax Expense
0
0
0
-1
0
1
0
-
-55,851,444
-
Net Income
-18
-22
-38
-60
-37
-57
-62
-37
-55
-33
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Aldeyra The Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-4
-8
-16
-15
-15
-9
-9
-7
23,164,777
Operating Cash Flow
0
-9
-13
-7
-12
-12
-8
-7
-5
Investing Cash Flow
-
-30
-18
5
-1
7
0
25
16
Financing Cash Flow
-1
0
-
0
0
1
1,002,808
0
-2,005,617
Change in Cash
0
-90
-21
-2
-13
-4
-9
18
10

Aldeyra The Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-38
-60
-37
-57
-62
-37
-55
-33,846,661
Operating Cash Flow
-19
-29
-44
-37
-42
-56
-30
-43
-33,345,682
Investing Cash Flow
-10
-23
18
29
0
-29
30
-44
47,736,288
Financing Cash Flow
37
80
23
41
194
1
-1
0
1,123,556
Change in Cash
8
27
-2
33
151
-85
-1
-88
15,514,162

Global Institutional Holdings in Aldeyra The

Funds
Holdings
Deutsche Bank AG
0.51%
683 Capital Management LLC
2.54%
Dimensional Fund Advisors, Inc.
1.02%
Wells Fargo & Co
0.6%
Perceptive Advisors LLC
8.68%
See all

Insights on Aldeyra The

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.1% return, outperforming this stock by 105.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 59.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ALDX stock has moved down by -64.3%

About Aldeyra The

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
OrganisationAldeyra The
Headquarters131 Hartwell Avenue, Lexington, MA, United States, 02421
IndustryBiotechnology
CEODr. Todd C. Brady M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Aldeyra The

Name

Title

Dr. Adam Lazorchak

Director of Translational Sciences & Non-Clinical Development

Dr. Todd C. Brady M.D., Ph.D.

CEO, President & Director

Mr. Michael Alfieri

Head of Finance and Principal Financial & Accounting Officer

David Burke

Head of Investor Relations

Laura Nichols

Operations Manager

FAQs

What is Aldeyra The share price today?

Aldeyra The share price today is $1.69 as on at the close of the market. Aldeyra The share today touched a day high of $1.83 and a low of $1.68.

What is the 52 week high and 52 week low for Aldeyra The share?

Aldeyra The share touched a 52 week high of $6.18 on and a 52 week low of $1.07 on . Aldeyra The stock price today i.e. is closed at $1.69,which is 72.63% down from its 52 week high and 57.94% up from its 52 week low.

What is Aldeyra The's market capitalisation today?

Aldeyra The market capitalisation is $0.00T as on .

How to invest in Aldeyra The Stock (ALDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aldeyra The on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aldeyra The Shares that will get you 0.8876 shares as per Aldeyra The share price of $1.69 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aldeyra The Stock (ALDX) from India?

Indian investors can start investing in Aldeyra The (ALDX) shares with as little as ₹93.505 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Aldeyra The stock (as per the Rupee-Dollar exchange rate as on ). Based on Aldeyra The share’s latest price of $1.69 as on April 22, 2026 at 1:29 am IST, you will get 5.9172 shares of Aldeyra The. Learn more about fractional shares .

What are the returns that Aldeyra The has given to Indian investors in the last 5 years?

Aldeyra The stock has given -84.97% share price returns and 23.44% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?